NASDAQ : OCUL

Ocular Therapeutix, Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 6.97 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.53B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Ocular Therapeutix, Inc. (OCUL) reported revenue of 52.05M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue52.05M51.95M63.72M58.44M51.49M43.52M
Cost of Revenue230.22M203.67M133.26M66.34M58.00M54.49M
Gross Profit-178.16M-151.72M-69.54M-7.89M-6.51M-10.97M
Selling, General & Admin135.75M118.30M91.34M74.49M72.15M67.07M
Operating Expenses135.75M118.30M91.34M74.49M72.15M67.07M
Operating Income-313.91M-270.02M-160.88M-82.38M-78.65M-78.04M
Interest Expense-11.40M-11.84M-13.58M-11.34M-7.02M-6.67M
Interest & Investment Income22.57M18.36M20.28M3.98M798.00K33.00K
Other Non Operating Income (Expenses)1.32M-2.44M-480.00K-5.19M13.84M78.12M
EBT Excluding Unusual Items-301.42M-265.94M-154.66M-94.93M-71.04M-6.55M
Merger & Restructuring Charges-1.60M
Other Unusual Items-37.25M14.19M
Pretax Income-301.45M-265.94M-193.51M-80.74M-71.04M-6.55M
Net Income-301.45M-265.94M-193.51M-80.74M-71.04M-6.55M
Net Income to Common-301.45M-265.94M-193.51M-80.74M-71.04M-6.55M
Shares Outstanding (Basic)214.00M187.24M158.27M79.83M76.88M76.39M
Shares Outstanding (Diluted)214.00M187.24M158.27M85.60M82.64M82.16M
EPS (Basic)-1.41-1.42-1.22-1.01-0.92-0.09
EPS (Diluted)-1.41-1.42-1.22-1.02-0.97-0.98
Free Cash Flow-255.10M-216.89M-135.97M-76.32M-63.32M-66.74M
Free Cash Flow Per Share-1.19-1.16-0.86-0.89-0.77-0.81
Gross Margin-292.04%-109.12%-13.51%-12.64%-25.20%
Operating Margin-603.03%-519.75%-252.47%-140.96%-152.74%-179.31%
Profit Margin-579.09%-511.90%-303.67%-138.15%-137.95%-15.06%
Free Cash Flow Margin-490.06%-417.50%-213.37%-130.59%-122.96%-153.36%
EBITDA-308.46M-265.69M-157.09M-79.40M-76.55M-75.62M
EBITDA Margin-246.53%-135.86%-148.65%-173.74%
D&A For EBITDA5.45M4.32M3.79M2.98M2.11M2.42M
EBIT-313.91M-270.02M-160.88M-82.38M-78.65M-78.04M
EBIT Margin-252.47%-140.96%-152.74%-179.31%
Revenue as Reported52.05M51.95M63.72M58.44M51.49M43.52M
Advertising Expenses505.00K917.00K880.00K

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents598.64M737.06M392.10M195.81M102.30M164.16M
Cash & Short-Term Investments598.64M737.06M392.10M195.81M102.30M164.16M
Accounts Receivable30.26M30.65M32.39M26.18M21.32M21.14M
Other Receivables176.00K
Receivables30.26M30.65M32.56M26.18M21.32M21.14M
Inventory3.83M3.56M3.04M2.31M1.97M1.25M
Prepaid Expenses11.70M10.86M13.28M7.79M4.03M4.75M
Restricted Cash150.00K
Total Current Assets644.43M782.13M440.99M232.24M129.63M191.30M
Property, Plant & Equipment25.28M24.31M15.33M18.21M17.90M11.82M
Other Long-Term Assets1.61M1.61M1.61M1.61M1.76M1.76M
Total Assets671.32M808.06M457.94M252.06M149.29M204.89M
Accounts Payable7.00M4.15M4.18M4.39M5.12M4.59M
Accrued Expenses39.06M43.84M35.12M28.67M24.10M20.12M
Current Portion of Leases3.12M2.82M1.93M1.59M1.60M1.62M
Current Unearned Revenue128.00K255.00K576.00K
Total Current Liabilities49.17M50.81M41.35M34.90M31.39M26.34M
Long-Term Debt72.80M71.34M68.50M74.92M54.01M51.44M
Long-Term Leases3.47M2.81M5.34M6.88M8.68M5.92M
Long-Term Unearned Revenue14.00M14.00M14.00M14.13M13.39M13.00M
Other Long-Term Liabilities11.84M14.79M13.39M30.09M6.44M20.19M
Total Liabilities151.28M153.75M142.59M160.93M113.91M116.89M
Common Stock22.00K22.00K16.00K12.00K8.00K8.00K
Additional Paid-In Capital1.84B1.81B1.21B788.70M652.21M633.79M
Retained Earnings-1.32B-1.16B-891.08M-697.58M-616.84M-545.80M
Shareholders' Equity520.04M654.31M315.34M91.13M35.38M88.00M
Total Liabilities & Equity671.32M808.06M457.94M252.06M149.29M204.89M
Total Debt79.38M76.97M75.78M83.39M64.28M58.98M
Net Cash (Debt)519.26M660.09M316.32M112.42M38.02M105.18M
Net Cash Per Share2.433.532.001.310.461.28
Filing Date Shares Outstanding219.62M217.69M159.02M148.63M77.51M76.75M
Total Common Shares Outstanding219.59M215.93M157.75M114.96M77.20M76.73M
Working Capital595.25M731.32M399.63M197.34M98.23M164.96M
Book Value Per Share2.373.032.000.790.461.15
Tangible Book Value520.04M654.31M315.34M91.13M35.38M88.00M
Tangible Book Value Per Share2.373.032.000.790.461.15
Machinery21.33M18.05M16.78M13.75M12.28M
Construction In Progress10.26M119.00K281.00K4.07M578.00K
Leasehold Improvements15.28M14.53M14.70M9.07M9.07M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-301.45M-265.94M-193.51M-80.74M-71.04M-6.55M
Depreciation & Amortization5.45M4.32M3.79M2.98M2.11M2.42M
Loss (Gain) From Sale of Assets4.87M-29.00K1.00K1.00K-1.00K
Stock-Based Compensation53.28M43.18M33.11M17.82M16.96M14.98M
Other Operating Activities1.98M5.87M32.16M-2.90M-8.99M-73.49M
Change in Accounts Receivable151.00K1.74M-6.21M-4.85M-190.00K-8.88M
Change in Inventory-787.00K-524.00K-735.00K-331.00K-724.00K-49.00K
Change in Accounts Payable1.29M-887.00K-318.00K583.00K-621.00K1.80M
Change in Unearned Revenue-128.00K-262.00K427.00K963.00K1.00M
Change in Other Net Operating Assets-3.02M7.51M-2.71M-3.24M1.92M3.23M
Operating Cash Flow-238.24M-204.88M-134.68M-70.23M-59.60M-65.55M
Capital Expenditures-16.86M-12.01M-1.29M-6.09M-3.71M-1.19M
Sale of Property, Plant & Equipment130.00K
Investing Cash Flow-16.86M-11.88M-1.29M-6.09M-3.71M-1.19M
Short-Term Debt Issued2.00M
Long-Term Debt Issued82.47M3.72M
Total Debt Issued84.47M3.72M
Short-Term Debt Repaid-2.00M
Long-Term Debt Repaid-26.12M-4.17M
Total Debt Repaid-28.12M-4.17M
Net Debt Issued (Repaid)56.35M-445.00K
Issuance of Common Stock462.61M561.72M332.11M118.66M1.45M3.57M
Other Financing Activities-5.18M-275.00K
Financing Cash Flow462.61M561.72M332.11M169.83M1.45M2.85M
Net Cash Flow207.51M344.96M196.15M93.51M-61.86M-63.89M
Free Cash Flow-255.10M-216.89M-135.97M-76.32M-63.32M-66.74M
Free Cash Flow Margin-490.06%-417.50%-213.37%-130.59%-122.96%-153.36%
Free Cash Flow Per Share-1.19-1.16-0.86-0.89-0.77-0.81
Levered Free Cash Flow-159.25M-128.28M-79.78M-49.44M-33.30M-38.07M
Unlevered Free Cash Flow-152.12M-120.88M-71.29M-42.35M-28.91M-33.90M
Cash Interest Paid8.94M9.03M21.53M5.46M2.15M1.93M
Change in Working Capital-2.37M7.71M-10.23M-7.41M1.35M-2.90M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.48B2.59B1.34B491.58M216.40M533.97M
Enterprise Value958.76M2.32B990.54M464.04M155.15M413.42M
Last Close Price6.9712.148.544.462.816.97
PS Ratio28.5649.7821.078.414.2012.27
PB Ratio2.943.954.265.396.126.07
P/TBV Ratio2.863.954.265.396.126.07
EV/Sales Ratio18.5944.6315.547.943.019.50
Debt / Equity Ratio0.150.120.240.921.820.67
Net Debt / Equity Ratio-1.00-1.01-1.00-1.23-1.07-1.20
Net Debt / EBITDA Ratio1.682.482.011.420.501.39
Net Debt / FCF Ratio2.043.042.331.470.601.58
Asset Turnover0.090.080.180.290.290.19
Inventory Turnover67.0761.6849.8631.0035.9844.46
Quick Ratio12.7915.1110.276.363.947.04
Current Ratio13.1115.3910.666.664.137.26
Return on Equity (ROE)-72.99%-54.85%-95.21%-127.64%-115.16%-7.99%
Return on Assets (ROA)-34.95%-26.66%-28.32%-25.66%-27.76%-20.90%
Return on Capital Employed (ROCE)-50.50%-35.70%-38.60%-37.90%-66.70%-43.70%
Earnings Yield-21.01%-10.28%-14.41%-16.42%-32.83%-1.23%
FCF Yield-17.16%-8.39%-10.13%-15.53%-29.26%-12.50%
Buyback Yield / Dilution-26.40%-18.31%-84.90%-3.57%-0.59%-35.24%